CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Derivatives Options or other derivatives
- 4 Conversion Director acquired 12,858,194 shares (conversion)
- 4 Conversion 10% owner acquired 12,858,194 shares (conversion)
- 4 Conversion Director acquired 427,292 shares (conversion)
- 4 Open-market buy Director bought 411,700 shares at $19.00 ($7,822,300)
- 4 Conversion Director acquired 10,552 shares (conversion)
- 4 Conversion Director acquired 24,621 shares (conversion)
- 4 Open-market buy Director bought 411,700 shares at $19.00 ($7,822,300)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 15 of 16 · 301 filings